Evaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia

J Drugs Dermatol. 2022 Nov 1;21(11):1166-1169. doi: 10.36849/JDD.6750.

Abstract

Androgenetic alopecia (AGA) in men and women is the most common cause of hair loss. Affected individuals may experience psychological distress and social withdrawal. Current treatment options for AGA, such as minoxidil and finasteride, vary in efficacy and have side effects. Platelet-rich plasma (PRP) and photobiomodulation are among treatment options that have gained popularity in recent years. While less is known about the effectiveness of fractional lasers for combating hair loss, research suggests that by creating microscopic thermal injury zones, fractional lasers may cause an increase in hair growth from a wound healing process. In this study, we evaluated the efficacy and safety of PRP and 1550 nm fractional erbium-glass laser as monotherapy or combination treatment for AGA in 60 patients. All patients experienced improvement in AGA, but patients treated with the combination therapy had greater improvement in hair density. Overall, PRP and 1550 nm in combination or alone are good treatment choices for AGA, with no side effects. J Drugs Dermatol. 2022;21(11):1166-1169. doi:10.36849/JDD.6750.

MeSH terms

  • Alopecia / chemically induced
  • Alopecia / diagnosis
  • Alopecia / therapy
  • Female
  • Finasteride / therapeutic use
  • Humans
  • Lasers, Solid-State* / adverse effects
  • Male
  • Minoxidil
  • Platelet-Rich Plasma*
  • Treatment Outcome

Substances

  • Minoxidil
  • Finasteride